Lundbeck has expressed interest in acquiring Xeris Biopharma, a commercial-stage drugmaker, people familiar with the matter said.
Lundbeck eyes acquisition of Xeris Biopharma
Lundbeck has expressed interest in acquiring Xeris Biopharma, a commercial-stage drugmaker, according to people familiar with the matter.